Phase II trial of preoperative bevacizumab (Bev), irinotecan (I), cisplatin (C), and radiation (RT) in esophageal adenocarcinoma: Preliminary safety analysis Meeting Abstract


Authors: Ilson, D.; Bains, M.; Rizk, N.; Rusch, V.; Flores, R.; Park, B.; Shah, M.; Kelsen, D.; Miron, B.; Goodman, K.
Abstract Title: Phase II trial of preoperative bevacizumab (Bev), irinotecan (I), cisplatin (C), and radiation (RT) in esophageal adenocarcinoma: Preliminary safety analysis
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 15 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-05-20
Start Page: 220s
Language: English
ACCESSION: WOS:000276606603163
PROVIDER: wos
Notes: Meeting Abstract: 4573 -- Source: Wos
MSK Authors
  1. Valerie W Rusch
    652 Rusch
  2. Karyn A Goodman
    244 Goodman
  3. Nabil Rizk
    134 Rizk
  4. Raja Flores
    107 Flores
  5. Bernard J Park
    155 Park
  6. Manish Shah
    174 Shah
  7. David H Ilson
    269 Ilson
  8. Manjit S Bains
    227 Bains
  9. David P Kelsen
    332 Kelsen
  10. Benjamin Miron
    4 Miron